![Lars Thomander](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Thomander
Corporate Officer/Principal presso University of Uppsala
Posizioni attive di Lars Thomander
Società | Posizione | Inizio | Fine |
---|---|---|---|
University of Uppsala | Corporate Officer/Principal | - | - |
Storia della carriera di Lars Thomander
Precedenti posizioni note di Lars Thomander
Società | Posizione | Inizio | Fine |
---|---|---|---|
Abbott Scandinavia AB | Direttore Tecnico/Scientifico/R&S | 01/01/2009 | 01/01/2013 |
AbbVie AB
![]() AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Direttore Tecnico/Scientifico/R&S | 01/01/2009 | 01/01/2013 |
ELI LILLY AND COMPANY | Direttore Tecnico/Scientifico/R&S | - | - |
Foundation for Pharmaceutical Medicine | Direttore/Membro del Consiglio | - | - |
Swedish Pharmaceutical Society | Presidente | - | - |
Hlt Konsult AB | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - | |
CaptiGel AB
![]() CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Presidente | 01/01/2014 | - |
Double Bond Pharmaceutical International AB
![]() Double Bond Pharmaceutical International AB BiotechnologyHealth Technology Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and life-threatening disorders. It also involves in designing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes. The company was founded on November 21, 2014 and is headquartered in Uppsala, Sweden. | Direttore/Membro del Consiglio | 01/04/2015 | - |
Statistiche
Distribuzione geografica
Svezia | 9 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Chairman | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
![]() | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Aziende private | 6 |
---|---|
CaptiGel AB
![]() CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Health Technology |
Hlt Konsult AB | |
Abbott Scandinavia AB | |
AbbVie AB
![]() AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Commercial Services |
Swedish Pharmaceutical Society | |
Foundation for Pharmaceutical Medicine |
- Borsa valori
- Insiders
- Lars Thomander
- Esperienza